 Chloe Page
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prefrontal Cortex | 4 | 2019 | 301 | 1.600 |
Why?
| | Anxiety | 6 | 2023 | 1035 | 1.340 |
Why?
| | Stress, Psychological | 6 | 2019 | 1100 | 1.270 |
Why?
| | Neuronal Plasticity | 3 | 2024 | 290 | 0.920 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2023 | 50 | 0.840 |
Why?
| | Neurogenesis | 2 | 2022 | 149 | 0.830 |
Why?
| | Parvalbumins | 3 | 2019 | 25 | 0.830 |
Why?
| | Amygdala | 4 | 2023 | 191 | 0.800 |
Why?
| | Interneurons | 2 | 2023 | 122 | 0.800 |
Why?
| | Serotonin | 1 | 2024 | 323 | 0.740 |
Why?
| | Depressive Disorder, Major | 1 | 2024 | 364 | 0.660 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2023 | 165 | 0.660 |
Why?
| | Cortical Excitability | 1 | 2019 | 3 | 0.640 |
Why?
| | Sleep Wake Disorders | 1 | 2023 | 286 | 0.620 |
Why?
| | Affective Symptoms | 1 | 2019 | 53 | 0.610 |
Why?
| | Neural Inhibition | 1 | 2019 | 169 | 0.570 |
Why?
| | Sex Characteristics | 3 | 2019 | 762 | 0.520 |
Why?
| | Antipsychotic Agents | 1 | 2018 | 194 | 0.510 |
Why?
| | Behavior, Animal | 1 | 2019 | 501 | 0.500 |
Why?
| | Schizophrenia | 1 | 2018 | 439 | 0.430 |
Why?
| | Depression | 3 | 2019 | 1397 | 0.420 |
Why?
| | Neurons | 6 | 2023 | 1590 | 0.420 |
Why?
| | Perimenopause | 2 | 2023 | 63 | 0.390 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2607 | 0.330 |
Why?
| | Menopause | 2 | 2023 | 320 | 0.330 |
Why?
| | Mental Health | 2 | 2024 | 726 | 0.270 |
Why?
| | Hippocampus | 4 | 2021 | 895 | 0.260 |
Why?
| | Brain | 3 | 2024 | 2668 | 0.250 |
Why?
| | Lisdexamfetamine Dimesylate | 1 | 2024 | 8 | 0.220 |
Why?
| | Salpingo-oophorectomy | 1 | 2024 | 18 | 0.220 |
Why?
| | Postmenopause | 2 | 2023 | 366 | 0.220 |
Why?
| | Shaw Potassium Channels | 1 | 2023 | 4 | 0.220 |
Why?
| | Basolateral Nuclear Complex | 1 | 2023 | 11 | 0.220 |
Why?
| | Premenstrual Dysphoric Disorder | 1 | 2023 | 19 | 0.200 |
Why?
| | Living Donors | 1 | 2025 | 295 | 0.200 |
Why?
| | Premenopause | 1 | 2023 | 131 | 0.190 |
Why?
| | Antidepressive Agents | 1 | 2024 | 236 | 0.190 |
Why?
| | Emigrants and Immigrants | 1 | 2024 | 136 | 0.190 |
Why?
| | Cross-Over Studies | 1 | 2024 | 564 | 0.190 |
Why?
| | Neural Stem Cells | 1 | 2023 | 156 | 0.190 |
Why?
| | Executive Function | 2 | 2024 | 451 | 0.180 |
Why?
| | Puberty | 1 | 2022 | 146 | 0.180 |
Why?
| | Tissue and Organ Procurement | 1 | 2025 | 321 | 0.170 |
Why?
| | MicroRNAs | 2 | 2018 | 692 | 0.170 |
Why?
| | Female | 12 | 2025 | 73304 | 0.160 |
Why?
| | Maternal Deprivation | 1 | 2019 | 16 | 0.160 |
Why?
| | Animals | 8 | 2023 | 36940 | 0.150 |
Why?
| | Cognition | 2 | 2023 | 1153 | 0.140 |
Why?
| | GABAergic Neurons | 1 | 2018 | 35 | 0.140 |
Why?
| | Mast Cells | 1 | 2019 | 147 | 0.140 |
Why?
| | Mice | 4 | 2023 | 17787 | 0.140 |
Why?
| | Humans | 12 | 2025 | 137585 | 0.130 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 219 | 0.130 |
Why?
| | Prosencephalon | 1 | 2016 | 48 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5472 | 0.120 |
Why?
| | Male | 8 | 2025 | 67762 | 0.110 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2016 | 198 | 0.110 |
Why?
| | Disease Models, Animal | 3 | 2019 | 4295 | 0.110 |
Why?
| | Memory | 1 | 2016 | 248 | 0.110 |
Why?
| | Mice, Inbred C57BL | 3 | 2018 | 5757 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2022 | 6079 | 0.090 |
Why?
| | Adolescent | 3 | 2025 | 21513 | 0.080 |
Why?
| | Adult | 6 | 2025 | 37929 | 0.060 |
Why?
| | Child | 2 | 2022 | 21935 | 0.060 |
Why?
| | Altruism | 1 | 2025 | 27 | 0.060 |
Why?
| | Vulnerable Populations | 1 | 2024 | 163 | 0.050 |
Why?
| | Central Nervous System Stimulants | 1 | 2024 | 161 | 0.050 |
Why?
| | United States | 3 | 2025 | 14841 | 0.050 |
Why?
| | Data Collection | 1 | 2024 | 673 | 0.050 |
Why?
| | Chronic Disease | 2 | 2018 | 1793 | 0.040 |
Why?
| | Affect | 1 | 2023 | 292 | 0.040 |
Why?
| | Motivation | 1 | 2025 | 570 | 0.040 |
Why?
| | Women's Health | 1 | 2023 | 372 | 0.040 |
Why?
| | Estradiol | 1 | 2023 | 521 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1993 | 0.040 |
Why?
| | Neuroimmunomodulation | 1 | 2019 | 65 | 0.040 |
Why?
| | Sirtuin 1 | 1 | 2018 | 30 | 0.040 |
Why?
| | Cell Count | 1 | 2019 | 324 | 0.040 |
Why?
| | Hypothalamus | 1 | 2019 | 153 | 0.040 |
Why?
| | Ovarian Neoplasms | 1 | 2024 | 565 | 0.040 |
Why?
| | Research Design | 1 | 2024 | 1139 | 0.040 |
Why?
| | PTEN Phosphohydrolase | 1 | 2018 | 167 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2019 | 844 | 0.030 |
Why?
| | Syntaxin 1 | 1 | 2016 | 13 | 0.030 |
Why?
| | Spatial Memory | 1 | 2016 | 26 | 0.030 |
Why?
| | Glutamate Decarboxylase | 1 | 2016 | 170 | 0.030 |
Why?
| | Acute Disease | 1 | 2018 | 1007 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2016 | 185 | 0.030 |
Why?
| | Up-Regulation | 1 | 2018 | 843 | 0.030 |
Why?
| | Nucleus Accumbens | 1 | 2016 | 138 | 0.030 |
Why?
| | Synaptic Transmission | 1 | 2016 | 289 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 243 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2486 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2021 | 1991 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2167 | 0.030 |
Why?
| | Middle Aged | 2 | 2025 | 33479 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 5778 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5647 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 971 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3015 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1774 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 13209 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2833 | 0.020 |
Why?
|
|
Page's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|